WVU Medicine Fairmont Now Offering Low-Dose CT Lung Cancer Screening for "At-Risk" Individuals
By Connect-Bridgeport Staff on February 09, 2024
WVU Medicine Fairmont Medical Center is now a designated site for low-dose computed tomography (LDCT). The addition of this service increases accessibility to screening services for at-risk individuals.
Fairmont Medical Center, a campus of WVU Medicine J.W. Ruby Memorial Hospital, is accredited by the American College of Radiology (ACR) for LDCT lung cancer screening. Patients whose results require follow-up screening or diagnostics will be referred to the WVU Cancer
Institute, an ACR Lung Cancer Screening Center of Excellence.
Institute, an ACR Lung Cancer Screening Center of Excellence.
LDCT scanning is used to screen for masses or nodules that could indicate lung cancer while minimizing exposure to radiation. Preventive screening can detect cancer in its early stages when it is most treatable, improving the patient’s length and quality of life.
“We are thrilled to bring this life-saving technology to our community,” Kyle Chapman, M.D., Fairmont Medical Center Lung Cancer Screening Program lead pulmonologist, said. “The LDCT program has the potential to dramatically improve lung cancer outcomes for at-risk individuals. Early detection and intervention are key to combating this devastating disease.”
A patient is eligible if he or she:
- Is between the ages of 50-77.
- Has a > 20 pack year smoking history.
- Is a current smoker or has quit smoking in the past 15 years.
- Has not received a chest CT scan in the last 12 months.
To schedule an appointment, call 304-598-6516. For more information on WVU Medicine Fairmont Medical Center, visit WVUMedicine.org/Fairmont.
